Expertise in
10
conditions

Dr. Rachel A. Rabinovitch

Radiation Oncology
University Of Colorado Hospital Authority
10463 Park Meadows Dr Ste 111, 
Lone Tree, CO 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
University Of Colorado Hospital Authority
10463 Park Meadows Dr Ste 111, 
Lone Tree, CO 

Overview

Rachel Rabinovitch is a Radiation Oncologist practicing medicine in Lone Tree, Colorado.

Dr. Rabinovitch is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Hodgkin Lymphoma, Angiosarcoma, and Marginal Zone Lymphoma (MZL).

She is actively involved in clinical research, co-authoring 75 peer reviewed articles and participating in 8 clinical trials. Dr. Rabinovitch is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in CO

Hospital Affiliations

Uchealth Highlands Ranch Hospital
University Of Colorado Hospital Authority

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

University of Colorado Hospital Authority
10463 Park Meadows Dr Ste 111, Lone Tree, CO 80124

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 3
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Radiation
Study Phase: Phase 1
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Enrollment Status: Terminated
Publish Date: May 22, 2026
Intervention Type: Radiation
Study Phase: Phase 2
Hypofractionated, Comprehensive Radiation Therapy for Node-Positive Breast Cancer
Hypofractionated, Comprehensive Radiation Therapy for Node-Positive Breast Cancer
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Combination product
Study Drug: Adjuvant Hypofractionated Radiation
Study Phase: Phase 2
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Phase Ib Trial of Neoadjuvant AMG 232 (KRT-232) Concurrent With Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)
A Phase Ib Trial of Neoadjuvant AMG 232 (KRT-232) Concurrent With Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drug: MDM2 Inhibitor KRT-232
Study Phase: Phase 1
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
View 7 Less Clinical Trials

75 Total Publications

On the Road to Personalized Treatment Decision-Making for Patients With Ductal Carcinoma In Situ.
On the Road to Personalized Treatment Decision-Making for Patients With Ductal Carcinoma In Situ.
Journal: International journal of radiation oncology, biology, physics
Published: March 10, 2026
Similar Doctors
Expertise in
13
conditions
Dr. Tracey E. Schefter
Radiation Oncology
Expertise in
13
conditions
Dr. Tracey E. Schefter
Radiation Oncology
Referral may be required

University Of Colorado Hospital Authority

10463 Park Meadows Dr Ste 111, 
Lone Tree, CO 
 (0.1 miles away)
720-848-0100
Languages Spoken:
English
See accepted insurances

Tracey Schefter is a Radiation Oncologist practicing medicine in Lone Tree, Colorado. Dr. Schefter is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Adult Soft Tissue Sarcoma, Endometrial Cancer, and Lung Cancer.

Expertise in
37
conditions
Dr. Brian D. Kavanagh
Radiation Oncology
Expertise in
37
conditions
Dr. Brian D. Kavanagh
Radiation Oncology
Referral may be required

Office

1665 Aurora Ct Ste 1032, 
Aurora, CO 
 (15.1 miles away)
720-718-5160
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian Kavanagh is a Radiation Oncologist practicing medicine in Aurora, Colorado. Dr. Kavanagh is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Astrocytoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). Dr. Kavanagh is currently accepting new patients.

Expertise in
29
conditions
Dr. Jacob E. Shabason
Radiation Oncology
Expertise in
29
conditions
Dr. Jacob E. Shabason
Radiation Oncology
Referral may be required
Before you request

Rocky Mountain Cancer Centers LLP

10103 RidgeGate Pkwy, Ste G01, 
Lone Tree, CO 
 (1.1 miles away)
720-225-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jacob Shabason is a Radiation Oncologist practicing medicine in Lone Tree, Colorado. Dr. Shabason is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Adult Soft Tissue Sarcoma, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor. Dr. Shabason is board certified in American Board Of Radiology. Dr. Shabason is currently accepting new patients.

Frequently Asked Questions about Dr. Rachel A. Rabinovitch

How do I make an appointment with Dr. Rachel A. Rabinovitch?

You can book an appointment with Dr. Rachel A. Rabinovitch by calling their office at 720-848-5400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rachel A. Rabinovitch a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rachel A. Rabinovitch is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rachel A. Rabinovitch specialize in?

While Dr. Rachel A. Rabinovitch is a Radiation Oncology, they have specific expertise in Breast Cancer, Hodgkin Lymphoma, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Rachel A. Rabinovitch participate in research or clinical trials?

Yes. Dr. Rachel A. Rabinovitch has published 75 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Rachel A. Rabinovitch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rachel A. Rabinovitch accept my insurance?

Dr. Rachel A. Rabinovitch accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 720-848-5400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rabinovitch's expertise for a condition
ConditionClose
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile